PHILADELPHIA, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD), today announced that one oral presentation and five posters across its development programs will be included at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2023, being held August 29 – September 1, 2023 in Jerusalem, Israel.
Oral Presentation:
Pompe Disease:
Abstract Title: Switching treatment from alglucosidase alfa to cipaglucosidase alfa plus miglustat positively affects motor function and quality of life in patients with late-onset Pompe disease
- Presenter: Priya Kishnani, MD, MBBS, Duke University Medical Center, Durham, NC, U.S.A.
- Session: Clinical Studies & Outcomes I
- Date and time: Wednesday, August 30, 8:45-9:00 a.m. I.D.T.
- Location: Oren 2
Poster Sessions:
Fabry Disease:
Abstract Title: Multiorgan involvement in females with Fabry disease: ...